Reportlinker.com announces that a new market research report is available in its catalogue.
Reportlinker Adds DNA Vaccines: Technologies and Global Markets
http://www.reportlinker.com/p0148904/Reportlinker-Adds-DNA-Vaccines-Technologies-and-Global-Markets.html
STUDY GOALS AND OBJECTIVES
The goal for this study is to determine the specific applications and global market demand for DNA vaccine products over a 5-year period from 2009 to 2014. Our particular interest is to analyze and quantify the DNA vaccines market potential by disease type, end-use market, and technology. We also identify emerging growth opportunities in DNA vaccine delivery technologies, adjuvants, and synthetic genes.
Our key objective is to present a comprehensive analysis of the emerging DNA vaccine industry, with an emphasis on products and technologies that are commercially important in the 2009 to 2014 time period. The role of DNA vaccines within the overall vaccine industry is examined. We highlight high growth and market potential segments of the industry. This analysis provides a quantitative market basis for biotechnology, pharmaceutical, adjuvant, and gene delivery companies to make strategic choices about DNA vaccine technologies and markets. The report will be particularly useful to companies supplying DNA vaccine components and systems, including synthetic genes, DNA delivery technologies, and adjuvants.
In addition, the study will benefit a wide range of life-science companies that supply enabling technologies for vaccine discovery and development, such as micro fluidics, nanotechnology, and genomics and proteomics tools.
HIGHLIGHTS
- Presents a comprehensive analysis of the emerging global DNA vaccine industry
- Forecasts sales in the global market for DNA vaccines through 2014
- Highlights products and technologies that are commercially important in the 2009 to 2014 time period
- Quantifies the DNA vaccines market potential by disease, end use market and technology
- Identifies emerging growth opportunities in DNA vaccine delivery technologies, adjuvants and synthetic genes
- Includes company profiles along with patents by technology and patents by company.
REASONS FOR DOING THE STUDY
The vaccine industry is rapidly changing from a mostly empirical approach to a rational design approach. Rapid developments in molecular biology, DNA synthesis, and immunobiology enable rational design approaches. These technologies allow highly targeted vaccines aimed at specific epitopes. The result is new vaccines for a wider range of diseases than was previously feasible, including a new class of therapeutic vaccines. These new technologies allow pharmaceutical firms to discover and develop high-value vaccines for novel applications, creating a substantial new market opportunity.
DNA vaccines have many potential advantages, including specific targeting, use of multiple genes to enhance immunity, and reduced risk compared with conventional vaccines. Translating the advantages of DNA vaccines into the clinic has historically been difficult; however, new advances in the fields of vaccine design and DNA delivery are addressing the previous issues. Achievements in these fields promise to overcome the translational hurdles and create strategic opportunity. This report analyzes these trends and their effects on the future markets for DNA vaccines.
The technological and structural changes occurring in the vaccine industry are strong driving forces for revitalizing this particular market and providing new growth opportunities. It is important that biotechnology and pharmaceutical firms understand the technology and market dynamics within this industry in order to best develop strategic plans and actions.
Based on these market and technology dynamics, it is especially timely to examine the future DNA vaccines markets.
INTENDED AUDIENCE
We have compiled a study of DNA vaccine technologies that will be commercially important in the major market segments, including cancer, infectious diseases, animal health, allergies, and biodefense.